KDM1B and cancer: However, a recent study demonstrated that type I interferon treatment of cancer cells increased the lysine specific demethylase KDM1B, which epigenetically reprograms cancer cells to generate cancer stem cells exhibiting properties of immune evasion and chemoresistance (29).